Nouvelles » Puzzle Medical Closes CAN$ 34 million Series A Funding Round
27 February 2023
Puzzle Medical Closes CAN$ 34 million Series A Funding Round
Puzzle Medical Closes CAN$ 34 million Series A Funding Round to Complete Human Feasibility Study Led by Cordis-X
Montréal, 3 juin 2021 –Puzzle Medical, a Montreal-based startup developing a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure, announced today the successful closing of its CAN$ 34 million Series A funding round led by Cordis-X, a Cardiovascular-Focused Investment Vehicle Backed by Ajax Health, Hellman &Friedman, and KKR. The round also included participation from Longview Ventures, Desjardins Capital, and BDC Capital’s Thrive Venture Fund, as well as existing investors.
The funding will be primarily used to complete the company’s Human Feasibility Study, which aims to evaluate the safety and efﬁcacy of the percutaneous heart pump. Puzzle Medical will also allocate resources towards expanding its development efforts and attracting top talent to facilitate its growth trajectory. In addition to this, the company is pleased to welcome Duke Rohlen, Aftab Kherani, and Maria Berkmant o its Board of Directors.
Read the full presse release here.